{
    "uniprot_canonical_ac": "A0A0R4IFY3-1",
    "uniprot_id": [
        {
            "id": "A0A0R4IFY3_DANRE",
            "url": "https://www.uniprot.org/uniprot/A0A0R4IFY3_DANRE",
            "type": "external"
        }
    ],
    "mass": 39743.0,
    "length": 345,
    "protein_name": "5-hydroxytryptamine (serotonin) receptor 5A, Genome duplicate A",
    "gene_name": "htr5aa",
    "organism": "Zebrafish",
    "refseq_name": "5-hydroxytryptamine (serotonin) receptor 5A, genome duplicate a",
    "refseq_ac": [
        {
            "id": "NP_001119882",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001119882",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "htr5aa; htr5a; si:dkey-265a7.5",
    "gene_names_refseq": "htr5a; si:dkey-265a7.5; htr5aa",
    "protein_names_uniprotkb": "5-hydroxytryptamine (serotonin) receptor 5A, Genome duplicate A",
    "protein_names_refseq": "5-hydroxytryptamine (serotonin) receptor 5A, genome duplicate a",
    "tax_id": 7955,
    "disease": "intracranial hypertension (Disease Ontology:DOID:9428)",
    "pathway": " (dre:100038775);  (R-DRE-390666);  (R-DRE-418594)",
    "pathway_count": 3,
    "publication_count": 9,
    "publication_id_list": "23594743;26565906;26822114;27424782;27703173;28837927;32209227;32892009;33171223",
    "function": "##Evidence-Data-START## RNAseq introns :: single sample supports all introns SAMEA4476767, SAMN01765705 [ECO:0000348] ##Evidence-Data-END## VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from CR855328.8 and BX510360.8. On or before May 28, 2009 this sequence version replaced NP_001083024.1, NP_001119882.1. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments., [RefSeq]",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 0,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 1,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0004993 G protein-coupled serotonin receptor activity;GO:0030594 neurotransmitter receptor activity;GO:0004938 alpha2-adrenergic receptor activity",
    "go_cellular_component": "GO:0005886 plasma membrane;GO:0030425 dendrite;GO:0045202 synapse",
    "go_biological_process": "GO:0007187 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;GO:0007268 chemical synaptic transmission;GO:0071881 adenylate cyclase-inhibiting adrenergic receptor signaling pathway",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0R4IFY3-1",
    "record_type": "protein",
    "filter_code": "0000000.0000111.100000.0000000000000001.00000.000"
}